Ceftazidime treatment in cystic fibrosis: resistant organisms in sputum and faeces.

Ceftazidime was used as the only intravenous agent for treating lower respiratory tract infections in patients with cystic fibrosis. The risks of inducing beta lactamases and conferring antibiotic resistance are high when monotherapy is used; so the emergence of resistant bacteria was studied prospe...

Full description

Saved in:
Bibliographic Details
Published in:Thorax
Main Authors: Dalzell, A M, Sunderland, D, Hart, C A, Heaf, D P
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 1991
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC463083/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1903896/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.46.4.239
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items